Latest Breaking News On - Marcin szumowski - Page 4 : comparemela.com

Molecure Appoints Dr Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing its Expanded Clinical Portfolio

Molecure Appoints Dr Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing its Expanded Clinical Portfolio
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrazer hallUnited kingdomWayne state universityYale universityEleanor perkinMarcin szumowskiEli lillyMarta borkowskaSamson fungAdam golebiowskiSandi greenwoodZbigniew zaslonaUniversity of freiburgDepartment of biochemistryWarsaw stock exchange

Molecure Appoints Dr Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing its Expanded Clinical Portfolio

Molecure Appoints Dr Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing its Expanded Clinical Portfolio
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomWayne state universityMolecure saSamson fungMarcin szumowskiEli lillyUniversity of freiburgDepartment of biochemistryUniversity of michiganSenior research fellow at molecureProcter gamble pharmaceuticalsVp research biologyTrinity college dublin irelandMarburg lung centerHead of clinical development

Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022

Molecure S.A. (“Molecure”: WSE: MOC) a clinical stage biotechnology company using its world leading medicinal chemistry capabilities to discover first-in-class small molecule drug candidates that directly modulate unexplored protein and RNA targets to treat multiple incurable diseases, announces agenda topics and .

United statesCezary szczylikRafal krenkeSamson fungMarcin szumowskiMolecure saNicolas beuzenHead of department internal medicineUniversity of warsawVp research biologyHead of the department clinical oncologyBusiness developmentUniversity of michiganKey opinion leadersOpinion leader presentersInternal medicine

Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022

/PRNewswire/ Molecure S.A. ("Molecure": WSE: MOC) a clinical stage biotechnology company using its world leading medicinal chemistry capabilities to.

United statesEleanor perkinRafal krenkeCezary szczylikFrazer hallMarcin szumowskiMarta borkowskaSamson fungNicolas beuzenSandi greenwoodYale universityFlemish institute for biotechnologyWarsaw stock exchangeInternational institute of molecularUniversity of michiganRutgers university

Molecure reports continued pipeline momentum for 6 months ended 30th June 2022

Our new name "Molecure" reflects expansion of scope of small molecule targets from novel proteins to mRNA in discovery & development of breakthrough therapies.

United statesEleanor perkinFrazer hallMarcin szumowskiMarta borkowskaNancy van osselaerSamson fungAgnieszka rajczuk szczepaSandi greenwoodYale universityFlemish institute for biotechnologyWarsaw stock exchangeCompany youtubeInternational institute of molecularUniversity of michiganRutgers university